ATE44149T1 - N,n-dialkylaminoalkyl-hexahydro-5-oxo-1hpyrrolizin-3-carboxamide. - Google Patents

N,n-dialkylaminoalkyl-hexahydro-5-oxo-1hpyrrolizin-3-carboxamide.

Info

Publication number
ATE44149T1
ATE44149T1 AT86113086T AT86113086T ATE44149T1 AT E44149 T1 ATE44149 T1 AT E44149T1 AT 86113086 T AT86113086 T AT 86113086T AT 86113086 T AT86113086 T AT 86113086T AT E44149 T1 ATE44149 T1 AT E44149T1
Authority
AT
Austria
Prior art keywords
dialkylaminoalkyl
hexahydro
oxo
carboxamide
amnesia
Prior art date
Application number
AT86113086T
Other languages
English (en)
Inventor
Donald E Butler
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of ATE44149T1 publication Critical patent/ATE44149T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT86113086T 1985-09-24 1986-09-23 N,n-dialkylaminoalkyl-hexahydro-5-oxo-1hpyrrolizin-3-carboxamide. ATE44149T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/779,712 US4638006A (en) 1985-09-24 1985-09-24 Amnesia reversal with N,N-dialkylaminoalkyl-hexahydro-5-oxo 1H-pyrrolizine-3-carboxamides
EP86113086A EP0219706B1 (de) 1985-09-24 1986-09-23 N,N-Dialkylaminoalkyl-hexahydro-5-oxo-1H-pyrrolizin-3-carboxamide

Publications (1)

Publication Number Publication Date
ATE44149T1 true ATE44149T1 (de) 1989-07-15

Family

ID=25117290

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86113086T ATE44149T1 (de) 1985-09-24 1986-09-23 N,n-dialkylaminoalkyl-hexahydro-5-oxo-1hpyrrolizin-3-carboxamide.

Country Status (5)

Country Link
US (1) US4638006A (de)
EP (1) EP0219706B1 (de)
JP (1) JPS6272690A (de)
AT (1) ATE44149T1 (de)
DE (1) DE3664044D1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
JPS58159493A (ja) * 1982-03-16 1983-09-21 Suntory Ltd ８−置換ピロリチジン誘導体およびその用途
US4551470A (en) * 1983-08-29 1985-11-05 Warner-Lambert Company Hexahydro-3,5-dioxo-1H-pyrrolizine-2-carboxylic acid and derivatives, and use for reversing electroconvulsive shock amnesia
US4563469A (en) * 1984-07-20 1986-01-07 Warner-Lambert Company Derivatives of N-[2-(tetrahydro-3,5-dioxo-1H-pyrrolizin-7a(5H)-yl)ethyl]amine as cognition activators

Also Published As

Publication number Publication date
JPS6272690A (ja) 1987-04-03
EP0219706A1 (de) 1987-04-29
US4638006A (en) 1987-01-20
DE3664044D1 (de) 1989-07-27
EP0219706B1 (de) 1989-06-21

Similar Documents

Publication Publication Date Title
FI873363A0 (fi) Foerfarande foer framstaellning av laekemedel med antitumoeraktivitet.
BG41820A3 (en) Method for preparing n- (3- hydroxy- 4- piperidinyl) benzamide derivatives
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
ATE22562T1 (de) 6-substituierte s-triazolo(3,4-a)phthalazinderivate.
YU211087A (en) Process for obtaining new n-substituted benzimidazolic derivatives
PL285248A1 (en) Method of obtaining novel aminophenol derivatives
DK93685A (da) Benzisoselenazolthioner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
DK550586A (da) Laegemiddel til behandling af neuropsykiatriske tilstande, saasom demens
GR71207B (de)
BG42003A3 (en) Method for preparing pyridyl compounds
BG41125A3 (en) Method for preparing benzamides
JO1406B1 (en) Chemical compounds
BG34907A3 (en) Method for preparing benzodiazepine compounds
SE8405588D0 (sv) New compounds
ATE46518T1 (de) Sialosylcerebroside und verfahren zu ihrer herstellung.
SE8404334D0 (sv) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
BG38637A3 (en) Method for preparing 2- exo- hydroxy- 7- oxabicyclo [2, 2, 1] heptanes
BG44203A3 (en) Method for preparing of 2- oxyindol- 1- carboxamides
CA1268468C (en) PROSTAGLANDIN ANALOGS WITH SUBSTITUTE THIABICYCLOHEPTAN GROUP
ATE44149T1 (de) N,n-dialkylaminoalkyl-hexahydro-5-oxo-1hpyrrolizin-3-carboxamide.
ATE40821T1 (de) Gesaettigte zykloalkyl-c-pyrrole-2(1h)essigs|ureamide und deren derivate.
ES473316A1 (es) Procedimiento para la obtencion de 1,4-dihidropiridazinas.
ATE41662T1 (de) Derivate von dihydro-1h-pyrrolo(1,2-c>imidazol3,5-dion zur aktivierung des wahrnehmungsvermoegens.
ATE34386T1 (de) 1,2,3,4-tetrahydro-1-aminomethyl-4-phenylisochinoline und verfahren zu ihrer herstellung.
FI875538A7 (fi) Uudet maleimideihin perustuvat yhdisteet ja uudet, niitä sisältävät valolla kovettuvat koostumukset.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee